Clinical and pathological features of glycogen storage disease type III

National Medical Journal of China

Volumn 89, Issue 15, 2009, Pages 1064-1066

  Dai, Ying Jie ^a   Chen, Lin ^a   Guo, Yu Pu ^a   Ren, Hai Tao ^a   Zhao, Yan Huan ^a   Wei, Min ^a   Qiu, Zheng Qing ^a   Song, Hong Mei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Glycogen storage disease; Muscular diseases; Pathology

Indexed keywords

ADRENALIN; FAT DROPLET; LIVER ENZYME; STARCH;

ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 3; GROWTH RETARDATION; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPOGLYCEMIA; LACTATE BLOOD LEVEL; MALE; METABOLIC ACIDOSIS; MUSCLE DISEASE; MYOPATHY; POSTPRANDIAL STATE; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; MALE; MUSCLE, SKELETAL; YOUNG ADULT;

EID: 77954928476     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.15.014     Document Type: Article

References (12)

1. Shen JJ, Chen YT. Molecular characterization of glycogen storage disease type III. Curr Mol Med, 2002,2:167-175. (Pubitemid 34649838)
2. Scriver CR, Beaudet AL, Sly WS, et al. The metabolic and molecular basic of inherited disease. 8th ed. New York: McGraw-Hill, 2001:1521-1551.
3. Demo E, Frush D, Gottfried M, et al. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol. 2007,46:492-498.
4. Momoi T, Sano H, Yamanaka C, et al. Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am Journal Med Genet, 1992,42:696-699.
5. Kiechl S, Kohlendorfer U, Thaler C, et al. Different clinical aspects of debrancher deficiency myopathy. J Neurol Neurosury Psychia try, 1999,67:364-368.
6. Labrune P, Huguet P, Odievre M. Cardiomyopathy in glycogenstorage disease type III: clinical and echographyic study of 18 patients. Pediatr Cardiol, 1991,12:161-163.
7. Moses SW, Bashan N, Wanderman KL, et al. Neuromucular involvement in glycogen storage disease type III. Acta Pediatr Scand, 1986,75:289-296. (Pubitemid 16137658)
8. Dimauro S, Hartwig GB, Hays A, et al. Dbrancher deficiency: neuromuscular disorder m 5 adults. Ann Neurol, 1979,5:422-436. (Pubitemid 9150134)
9. Iwamasa T, Fukuda S, Tokumitsu S, et al. Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation. Exp Mol Pathol, 1983,38:405-420.
10. Slonim AE, Coleman RA, Moses WS, et al. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein noctural enteral therapy. J Pediatr. 1984,105:906-911.